The Pharmaletter
One To Watch
Valbiotis
Valbiotis is an R&D company with a nutrition healthcare approach to developing solutions designed to prevent type 2 diabetes, NASH, (non-alcoholic steatohepatitis) and obesity.
The ambitious strap-line of the company outlines the target of a 'zero diabetes world'. Its products are made for manufacturers in the agri-food and pharmaceutical industries
Latest Valbiotis News
21 March 2018
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze